• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原始牙源性肿瘤:免疫组织化学特征

Primordial odontogenic tumor: An immunohistochemical profile.

作者信息

Bologna-Molina R, Mikami T, Pereira-Prado V, Pires F-R, Carlos-Bregni R, Mosqueda-Taylor A

机构信息

Health Care Department, Universidad Autónoma Metropolitana Xochimilco, Calzada del Hueso 1100, Villa Quietud, Mexico City 04960,

出版信息

Med Oral Patol Oral Cir Bucal. 2017 May 1;22(3):e314-e323. doi: 10.4317/medoral.21859.

DOI:10.4317/medoral.21859
PMID:28390134
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5432080/
Abstract

BACKGROUND

Primordial Odontogenic Tumor (POT) is a recently described odontogenic tumor characterized by a variably cellular loose fibrous tissue with areas similar to the dental papilla, covered by cuboidal to columnar epithelium that resembles the internal epithelium of the enamel organ, surrounded at least partly by a delicate fibrous capsule. The purpose of this study was to investigate the possible histogenesis and biological behavior of this rare tumor by means of a wide immunohistochemical analysis of its epithelial and mesenchymal components.

MATERIAL AND METHODS

The immunoexpression of twenty-three different antibodies were evaluated in four cases of POT.

RESULTS

The epithelial cells that cover the periphery of the tumor showed immunopositivity for Cytokeratins 14 and 19, while Amelogenin, Glut-1, MOC-31, Caveolin-1. Galectin-3, PITX2, p53, Bax, Bcl-2, Survivin and PTEN were variably expressed in focal areas. The mesenchymal component of the tumor was positive for Vimentin, Syndecan-1, PITX2, Endoglin (CD105), CD 34, Cyclin D1, Bax, Bcl-2, Survivin and p53. PTEN and CD 90 showed a moderate positivity. BRAF V600E and Calretinin were negative in all samples. Cell proliferation markers (Ki-67, MCM-7) were expressed in <5% of the tumor cells.

CONCLUSIONS

According to these immunohistochemical findings, we may conclude that POT is a benign odontogenic tumor in which there is both epithelial and mesenchymal activity during its histogenesis, as there is expression of certain components in particular zones in both tissues that suggests this tumor develops during the immature (primordial) stage of tooth development, leading to its inclusion within the group of benign mixed epithelial and mesenchymal odontogenic tumours in the current World Health Organization classification of these lesions.

摘要

背景

原始牙源性肿瘤(POT)是一种最近描述的牙源性肿瘤,其特征是具有不同细胞密度的疏松纤维组织,有类似于牙乳头的区域,表面覆盖着立方形至柱状上皮,类似于成釉器的内釉上皮,至少部分被一层薄的纤维包膜所包围。本研究的目的是通过对该罕见肿瘤的上皮和间充质成分进行广泛的免疫组织化学分析,探讨其可能的组织发生和生物学行为。

材料与方法

对4例POT病例评估了23种不同抗体的免疫表达情况。

结果

覆盖肿瘤周边的上皮细胞对细胞角蛋白14和19呈免疫阳性,而釉原蛋白、葡萄糖转运蛋白1、MOC-31、小窝蛋白-1、半乳糖凝集素-3、PITX2、p53、Bax、Bcl-2、生存素和PTEN在局部区域呈不同程度表达。肿瘤的间充质成分对波形蛋白、多配体蛋白聚糖-1、PITX2、内皮糖蛋白(CD105)、CD 34、细胞周期蛋白D1、Bax、Bcl-2、生存素和p53呈阳性。PTEN和CD 90呈中度阳性。BRAF V600E和钙视网膜蛋白在所有样本中均为阴性。细胞增殖标志物(Ki-67、微小染色体维持蛋白7)在<5%的肿瘤细胞中表达。

结论

根据这些免疫组织化学结果,我们可以得出结论,POT是一种良性牙源性肿瘤,在其组织发生过程中存在上皮和间充质活性,因为在两种组织的特定区域都有某些成分的表达,这表明该肿瘤在牙齿发育的不成熟(原始)阶段发生,从而使其被纳入世界卫生组织当前对这些病变的良性上皮和间充质混合性牙源性肿瘤分类中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdb4/5432080/a54bb9bc729f/medoral-22-e314-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdb4/5432080/16a79edc2454/medoral-22-e314-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdb4/5432080/3f22ecc1d173/medoral-22-e314-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdb4/5432080/a54bb9bc729f/medoral-22-e314-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdb4/5432080/16a79edc2454/medoral-22-e314-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdb4/5432080/3f22ecc1d173/medoral-22-e314-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdb4/5432080/a54bb9bc729f/medoral-22-e314-g003.jpg

相似文献

1
Primordial odontogenic tumor: An immunohistochemical profile.原始牙源性肿瘤:免疫组织化学特征
Med Oral Patol Oral Cir Bucal. 2017 May 1;22(3):e314-e323. doi: 10.4317/medoral.21859.
2
Primordial odontogenic tumor: A systematic review.原发性牙源性肿瘤:系统评价。
Med Oral Patol Oral Cir Bucal. 2020 May 1;25(3):e388-e394. doi: 10.4317/medoral.23432.
3
Primordial odontogenic tumor: Subepithelial expression of Syndecan-1 and Ki-67 suggests origin during early odontogenesis.原发性牙源性肿瘤:Syndecan-1 和 Ki-67 的上皮下表达提示其起源于早期牙源性发育过程中。
Oral Dis. 2018 Mar;24(1-2):72-77. doi: 10.1111/odi.12733.
4
Primordial odontogenic tumour: clinicopathological analysis of six cases of a previously undescribed entity.原发性牙源性肿瘤:一种此前尚未被描述的肿瘤六例临床病理分析。
Histopathology. 2014 Nov;65(5):606-12. doi: 10.1111/his.12451. Epub 2014 Sep 2.
5
Primordial Odontogenic Tumor: A case report with histopathological analyses.原始牙源性肿瘤:一例组织病理学分析报告
Pathol Int. 2017 Dec;67(12):638-643. doi: 10.1111/pin.12601. Epub 2017 Nov 1.
6
Pathogenesis of primordial odontogenic tumour based on tumourigenesis and odontogenesis.基于肿瘤发生和牙发生的原发性牙源性肿瘤发病机制。
Oral Dis. 2018 Oct;24(7):1226-1234. doi: 10.1111/odi.12914. Epub 2018 Jul 10.
7
Primordial odontogenic tumor with prominent calcifications.具有显著钙化的原发性牙源性肿瘤。
J Oral Sci. 2022 Oct 1;64(4):327-328. doi: 10.2334/josnusd.22-0028. Epub 2022 Sep 7.
8
A case of primordial odontogenic tumor: A new entity in the latest WHO classification (2017).一例原始性牙源性肿瘤:2017年世界卫生组织最新分类中的一个新实体。
Pathol Int. 2017 Jul;67(7):365-369. doi: 10.1111/pin.12543. Epub 2017 May 25.
9
Immunohistochemical localization of large chondroitin sulfate proteoglycan in odontogenic tumor.大硫酸软骨素蛋白聚糖在牙源性肿瘤中的免疫组织化学定位
Med Electron Microsc. 2002 Sep;35(3):173-7. doi: 10.1007/s007950200022.
10
Comparative histological and immunohistochemical study of ameloblastomas and ameloblastic carcinomas.成釉细胞瘤和成釉细胞癌的组织学及免疫组化对比研究
Med Oral Patol Oral Cir Bucal. 2017 May 1;22(3):e324-e332. doi: 10.4317/medoral.21901.

引用本文的文献

1
Histopathological spectrum of primordial odontogenic tumor with co-existing dentigerous cyst: 1 reported case of the world with a proposed 'updated diagnostic criteria'.伴有牙源性角化囊肿的原发性牙源性肿瘤的组织病理学谱:世界上 1 例报道病例,并提出了“更新的诊断标准”。
Diagn Pathol. 2024 Oct 29;19(1):143. doi: 10.1186/s13000-024-01560-8.
2
Primordial Odontogenic Tumor: A Decade Post-Description Systematic Review.原发性牙源性肿瘤:描述后十年的系统综述。
Head Neck Pathol. 2024 Oct 16;18(1):105. doi: 10.1007/s12105-024-01712-8.
3
Primordial odontogenic tumour: a case report.

本文引用的文献

1
Expression of CD90 and P75NTR stem cell markers in ameloblastomas: a possible role in their biological behavior.成釉细胞瘤中CD90和P75NTR干细胞标志物的表达:其在生物学行为中的可能作用。
Braz Oral Res. 2016 Oct 10;30(1):e109. doi: 10.1590/1807-3107BOR-2016.vol30.0109.
2
Reduction in membranous immunohistochemical staining for the intracellular domain of epithelial cell adhesion molecule correlates with poor patient outcome in primary colorectal adenocarcinoma.上皮细胞粘附分子细胞内结构域的膜免疫组化染色减少与原发性结直肠癌患者的不良预后相关。
Curr Oncol. 2016 Jun;23(3):e171-8. doi: 10.3747/co.23.3028. Epub 2016 Jun 9.
3
原始牙源性肿瘤:一例报告。
Hua Xi Kou Qiang Yi Xue Za Zhi. 2022 May 25;40(3):350-354. doi: 10.7518/hxkq.2022.03.016.
4
Prevalence of BRAF p.V600E and Detection Methods in Benign Mixed and Malignant Odontogenic Tumors: A Systematic Review.良性混合性和恶性牙源性肿瘤中 BRAF p.V600E 的流行率及检测方法:系统评价。
Head Neck Pathol. 2023 Dec;17(4):1000-1010. doi: 10.1007/s12105-023-01601-6. Epub 2023 Dec 6.
5
Primordial Odontogenic Tumor; Archival Review of 19380 Cases in a 55-Year Retrospective Study.原发性牙源性肿瘤;55 年回顾性研究中 19380 例病例的档案回顾。
Asian Pac J Cancer Prev. 2023 Aug 1;24(8):2845-2853. doi: 10.31557/APJCP.2023.24.8.2845.
6
Identification of BRAF V600E mutation in odontogenic tumors by high-performance MALDI-TOF analysis.应用高性能 MALDI-TOF 分析鉴定牙源性肿瘤中的 BRAF V600E 突变。
Int J Oral Sci. 2022 Apr 25;14(1):22. doi: 10.1038/s41368-022-00170-8.
7
Expression of caveolin-1 in tooth germ, ameloblastoma and ameloblastic carcinoma.牙胚、造釉细胞瘤和造釉细胞癌中窖蛋白-1 的表达。
Med Oral Patol Oral Cir Bucal. 2021 Mar 1;26(2):e238-e245. doi: 10.4317/medoral.24151.
8
Primordial odontogenic tumor: A systematic review.原发性牙源性肿瘤:系统评价。
Med Oral Patol Oral Cir Bucal. 2020 May 1;25(3):e388-e394. doi: 10.4317/medoral.23432.
9
Primordial odontogenic tumor: a case report and literature review.原发性牙源性肿瘤:一例报告及文献复习。
Diagn Pathol. 2019 Aug 17;14(1):92. doi: 10.1186/s13000-019-0867-4.
10
The Challenging Diagnosis of Primordial Odontogenic Tumor.原始性牙源性肿瘤的诊断难题
Case Rep Dent. 2019 Apr 24;2019:6415785. doi: 10.1155/2019/6415785. eCollection 2019.
Immunohistochemical Expression of GLUT-1 and HIF-1α in Tooth Germ, Ameloblastoma, and Ameloblastic Carcinoma.
葡萄糖转运蛋白1(GLUT-1)和缺氧诱导因子-1α(HIF-1α)在牙胚、成釉细胞瘤及成釉细胞癌中的免疫组化表达
Int J Surg Pathol. 2016 Aug;24(5):410-8. doi: 10.1177/1066896916640359. Epub 2016 Mar 28.
4
Assessment of CD-105 as an Angiogenic Modulator in Odontogenic Myxomas and Dental Follicles.评估CD-105作为牙源性黏液瘤和牙囊血管生成调节因子的作用。
Int J Surg Pathol. 2016 Jun;24(4):315-9. doi: 10.1177/1066896916632588. Epub 2016 Feb 16.
5
Primordial Odontogenic Tumor: Report of a Case.原始牙源性肿瘤:一例报告。
J Oral Maxillofac Surg. 2016 Mar;74(3):547-51. doi: 10.1016/j.joms.2015.08.019. Epub 2015 Sep 18.
6
Assessment of BRAFV600E and SMOF412E mutations in epithelial odontogenic tumours.上皮性牙源性肿瘤中BRAFV600E和SMOF412E突变的评估。
Tumour Biol. 2015 Jul;36(7):5649-53. doi: 10.1007/s13277-015-3238-0. Epub 2015 Feb 18.
7
Activating FGFR2-RAS-BRAF mutations in ameloblastoma.在造釉细胞瘤中激活 FGFR2-RAS-BRAF 突变。
Clin Cancer Res. 2014 Nov 1;20(21):5517-26. doi: 10.1158/1078-0432.CCR-14-1069. Epub 2014 Jul 3.
8
Identification of recurrent SMO and BRAF mutations in ameloblastomas.成釉细胞瘤中复发性SMO和BRAF突变的鉴定。
Nat Genet. 2014 Jul;46(7):722-5. doi: 10.1038/ng.2986. Epub 2014 May 25.
9
Primordial odontogenic tumour: clinicopathological analysis of six cases of a previously undescribed entity.原发性牙源性肿瘤:一种此前尚未被描述的肿瘤六例临床病理分析。
Histopathology. 2014 Nov;65(5):606-12. doi: 10.1111/his.12451. Epub 2014 Sep 2.
10
Concise review: evidence for CD34 as a common marker for diverse progenitors.简要综述:CD34作为多种祖细胞共同标志物的证据
Stem Cells. 2014 Jun;32(6):1380-9. doi: 10.1002/stem.1661.